Literature DB >> 36241730

PAX5 P80R-mutated B-cell acute lymphoblastic leukemia with transformation to histiocytic sarcoma: clonal evolution assessment using NGS-based immunoglobulin clonality and mutation analysis.

Leonie I Kroeze1, B Scheijen2,3, K M Hebeda2, J Rijntjes2, J A C W Luijks2, D Evers4, W Hobo5, P J T A Groenen2, M van den Brand2.   

Abstract

Clonality assessment by the detection of immunoglobulin (IG) gene rearrangements is an important method to determine whether two concurrent or subsequent lymphoid malignancies in one patient are clonally related. Here, we report the detailed clonality analysis in a patient with a diagnosis of B-cell acute lymphoblastic leukemia (B-ALL) followed by a histiocytic sarcoma (HS), in which we were able to study clonal evolution by applying next generation sequencing (NGS) to identify IG rearrangements and gene mutations. Using the sequence information of the NGS-based IG clonality analysis, multiple related subclones could be distinguished in the PAX5 P80R-mutated B-ALL. Notably, only one of these subclones evolved into HS after acquiring a RAF1 mutation. This case demonstrates that NGS-based IG clonality assessment and mutation analysis provide clear added value for clonal comparison and thereby improves clinicobiological understanding.
© 2022. The Author(s).

Entities:  

Keywords:  Acute lymphoblastic leukemia; Clonal evolution; Clonality analysis; Histiocytic sarcoma; Transformation

Year:  2022        PMID: 36241730     DOI: 10.1007/s00428-022-03428-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.535


  14 in total

1.  Pediatric histiocytic sarcoma clonally related to precursor B-cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A.

Authors:  Riten Kumar; Shakila P Khan; Divya-Devi Joshi; Gene R Shaw; Rhett P Ketterling; Andrew L Feldman
Journal:  Pediatr Blood Cancer       Date:  2011-02       Impact factor: 3.167

2.  PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome.

Authors:  Marie Passet; Nicolas Boissel; François Sigaux; Colombe Saillard; Mario Bargetzi; Ibrahima Ba; Xavier Thomas; Carlos Graux; Yves Chalandon; Thibaut Leguay; Etienne Lengliné; Johanna Konopacki; Samuel Quentin; Eric Delabesse; Marina Lafage-Pochitaloff; Cédric Pastoret; Nathalie Grardel; Vahid Asnafi; Véronique Lhéritier; Jean Soulier; Hervé Dombret; Emmanuelle Clappier
Journal:  Blood       Date:  2018-12-03       Impact factor: 22.113

Review 3.  Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature.

Authors:  Sarah Péricart; Charlotte Waysse; Aurore Siegfried; Stephanie Struski; Eric Delabesse; Camille Laurent; Solène Evrard
Journal:  Virchows Arch       Date:  2019-12-05       Impact factor: 4.064

4.  PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.

Authors:  Zhaohui Gu; Michelle L Churchman; Kathryn G Roberts; Ian Moore; Xin Zhou; Joy Nakitandwe; Kohei Hagiwara; Stephane Pelletier; Sebastien Gingras; Hartmut Berns; Debbie Payne-Turner; Ashley Hill; Ilaria Iacobucci; Lei Shi; Stanley Pounds; Cheng Cheng; Deqing Pei; Chunxu Qu; Scott Newman; Meenakshi Devidas; Yunfeng Dai; Shalini C Reshmi; Julie Gastier-Foster; Elizabeth A Raetz; Michael J Borowitz; Brent L Wood; William L Carroll; Patrick A Zweidler-McKay; Karen R Rabin; Leonard A Mattano; Kelly W Maloney; Alessandro Rambaldi; Orietta Spinelli; Jerald P Radich; Mark D Minden; Jacob M Rowe; Selina Luger; Mark R Litzow; Martin S Tallman; Janis Racevskis; Yanming Zhang; Ravi Bhatia; Jessica Kohlschmidt; Krzysztof Mrózek; Clara D Bloomfield; Wendy Stock; Steven Kornblau; Hagop M Kantarjian; Marina Konopleva; Williams E Evans; Sima Jeha; Ching-Hon Pui; Jun Yang; Elisabeth Paietta; James R Downing; Mary V Relling; Jinghui Zhang; Mignon L Loh; Stephen P Hunger; Charles G Mullighan
Journal:  Nat Genet       Date:  2019-01-14       Impact factor: 38.330

Review 5.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

Authors:  J J M van Dongen; A W Langerak; M Brüggemann; P A S Evans; M Hummel; F L Lavender; E Delabesse; F Davi; E Schuuring; R García-Sanz; J H J M van Krieken; J Droese; D González; C Bastard; H E White; M Spaargaren; M González; A Parreira; J L Smith; G J Morgan; M Kneba; E A Macintyre
Journal:  Leukemia       Date:  2003-12       Impact factor: 11.528

6.  Evaluation of a Hybrid Capture-Based Pan-Cancer Panel for Analysis of Treatment Stratifying Oncogenic Aberrations and Processes.

Authors:  Leonie I Kroeze; Richarda M de Voer; Eveline J Kamping; Daniel von Rhein; Erik A M Jansen; Mandy J W Hermsen; Massimo C P Barberis; Johan Botling; Eva M Garrido-Martin; Florian Haller; Ludovic Lacroix; Brigitte Maes; Sabine Merkelbach-Bruse; Valerie Pestinger; Nicole Pfarr; Albrecht Stenzinger; Michel M van den Heuvel; Katrien Grünberg; Marjolijn J L Ligtenberg
Journal:  J Mol Diagn       Date:  2020-03-20       Impact factor: 5.568

7.  Next-Generation Sequencing-Based Clonality Assessment of Ig Gene Rearrangements: A Multicenter Validation Study by EuroClonality-NGS.

Authors:  Michiel van den Brand; Jos Rijntjes; Markus Möbs; Julia Steinhilber; Michèle Y van der Klift; Kim C Heezen; Leonie I Kroeze; Tomas Reigl; Jakub Porc; Nikos Darzentas; Jeroen A C W Luijks; Blanca Scheijen; Frédéric Davi; Hesham ElDaly; Hongxiang Liu; Ioannis Anagnostopoulos; Michael Hummel; Falko Fend; Anton W Langerak; Patricia J T A Groenen
Journal:  J Mol Diagn       Date:  2021-06-26       Impact factor: 5.568

8.  CRAF R391W is a melanoma driver oncogene.

Authors:  Mohammad Atefi; Bjoern Titz; Jennifer Tsoi; Earl Avramis; Allison Le; Charles Ng; Anastasia Lomova; Amanda Lassen; Michael Friedman; Bartosz Chmielowski; Antoni Ribas; Thomas G Graeber
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

9.  Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS.

Authors:  Blanca Scheijen; Ruud W J Meijers; Jos Rijntjes; Michèle Y van der Klift; Markus Möbs; Julia Steinhilber; Tomas Reigl; Michiel van den Brand; Michaela Kotrová; Julia-Marie Ritter; Mark A Catherwood; Kostas Stamatopoulos; Monika Brüggemann; Frédéric Davi; Nikos Darzentas; Christiane Pott; Falko Fend; Michael Hummel; Anton W Langerak; Patricia J T A Groenen
Journal:  Leukemia       Date:  2019-06-13       Impact factor: 11.528

10.  The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy.

Authors:  Caoimhe Egan; Justin Lack; Shannon Skarshaug; Thu Anh Pham; Zied Abdullaev; Liqiang Xi; Svetlana Pack; Stefania Pittaluga; Elaine S Jaffe; Mark Raffeld
Journal:  Mod Pathol       Date:  2020-09-14       Impact factor: 8.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.